World Wires · story 33372 · official · 1 source(s)

SCHEDULE 13D/A: Fairmount Funds Management LLC discloses a stake in Spyre Therapeutics, Inc.

Filed: 2026-10-09 AccNo: 0001104659-26-115087 Size: 19 KB

Open in the desk

Coverage

• SCHEDULE 13D/A: Fairmount Funds Management LLC discloses a stake in Spyre Therapeutics, Inc. SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-10-09 21:00 UTC

What this site indexes